WebMay 24, 2024 · The chief executive of Hikma Pharmaceuticals PLC (AIM:HIK, OTC:HKMPF), Siggi Olafsson, has stepped down from the role, with a permanent replacement yet to be found. The British injectable medicine business announced today that Olafsson had resigned from the post and from Hikma’s board of directors after four years in the role. WebApr 12, 2024 · London, 12 April 2024 – Hikma Pharmaceuticals PLC (Hikma, Group), announces that Riad Mishlawi, President of the Group’s Injectables business, has been …
Hikma Pharmaceuticals PLC Announces Chief Executive Officer …
WebFeb 12, 2024 · The case opens with Said Darwazah, chairman and CEO of Hikma Pharmaceuticals, the multinational generics company, anticipating the company's 2024 AGM and reflecting on changes made over the previous year to address concerns expressed by proxy advisors and some shareholders about Hikma's reliance on a combined … Web2 days ago · AMMAN — Hikma Pharmaceuticals PLC (Hikma, Group), announced that Riad Mishlawi, president of the Group’s Injectables business, has been appointed chief … c/o bergen logistics nj299
Hikma Pharmaceuticals LinkedIn
WebApr 12, 2024 · He left Hikma in 1998 to join Watson Pharmaceuticals, where he was Executive Director of Operations. Riad returned to Hikma in 2004 and held a series of positions in the Group’s Injectables business including General Manager of Hikma’s injectable facilities in Italy and Portugal and Head of European Operations. WebApr 12, 2024 · Hikma Pharmaceuticals, a UK-listed company with operations in Europe, the Middle East, North Africa and the US, has appointed Riad Mishlawi as its chief executive. Mr Mishlawi, currently president of Hikma's injectables business, will assume his new role and join the company's board of directors on September 1, the company said on Wednesday. WebApr 12, 2024 · "Following an extensive, global search, I am very pleased that Hikma's board of directors has appointed Riad as Hikma's new CEO. The board believed that Riad was … cober